NEWS
Mesoblast says remestemcel-L will continue to be in demand
MELBOURNE: Mesoblast chairman Joseph Swedish says the company’s rock star drug remestemcel-L will continue to… read more
Meritless case cries out for reform of defamation laws
SYDNEY: The two Chelmsford Hospital doctors who sought vindication of their “deep sleep therapy” in… read more
Affordable housing in six unit project to be developed
BLAYNEY: Demand from expanding building projects and spillover from Orange and Bathurst has left Blayney’s… read more
